vimarsana.com

Latest Breaking News On - Nicole olszewski - Page 1 : vimarsana.com

TWi Biotechnology Exploring Promising Treatment for Granuloma Annulare (GA)

/PRNewswire/ TWi Biotechnology (TWiB), a clinical stage biopharmaceutical company specializing in development of repositioned drugs for unmet medical needs,.

T ai peiMichelle chenWilliam damskyNicole olszewskiYale school of medicineSource twi biotechnology incTwi biotechnology incYale university hospitalYale universityYale schoolTwi biotechnology

Yale tests a treatment for skin diseases that often target children

Yale dermatologists are playing a key role in testing a new treatment for an often-disfiguring group of skin diseases that develop in children.

United statesKeith choateNicole olszewskiChristina fleagleLeonard milstoneMahin dawood saffaChristopher bunickPeyton fleagleYale school of medicineAmerican academy of dermatologyDrug administrationTimber pharmaceuticalsYale department of dermatologyJournal of the american academy dermatologyYale centerYale new haven hospital

vimarsana © 2020. All Rights Reserved.